Katherine Seymour, MD
Internal Medicine · Nashville, TNNPI 1184914129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,324 and has fallen 98.4% since, to $22 in 2025.
Across 190 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$560
- GSK$364
- Amgen$273
- Pfizer$231
- Takeda Pharmaceuticals U.S.A., Inc.$192
- Merck$181
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,978100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $560 |
| GSK | 20 | $364 |
| Amgen | 19 | $273 |
| Pfizer | 14 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $192 |
| Merck | 18 | $181 |
| AstraZeneca | 12 | $171 |
| Lilly USA, LLC | 8 | $131 |
| Bayer | 6 | $129 |
| AbbVie(2 entities) | 6 | $128 |
| Abbott | 4 | $94 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Novartis | 3 | $53 |
| Exact Sciences | 3 | $53 |
| Johnson & Johnson | 3 | $49 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Genentech USA, Inc. | 1 | $25 |
| Stryker | 1 | $24 |
| Shield Therapeutics Inc | 1 | $20 |
| Eisai Inc. | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,978 in reported general payments places this provider in the 80th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 111 | $975 |
| Rosuvastatin Calcium | 31 | $604 |
| Losartan Potassium | 41 | $559 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $464 |
| Levothyroxine Sodium | 64 | $443 |
| Pravastatin Sodium | 31 | $440 |
| Pantoprazole Sodium | 29 | $414 |
| Tamsulosin Hcl | 26 | $410 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 14 | $398 |
| Metformin Hcl ErMetformin Hcl | 15 | $397 |
| Sertraline Hcl | 43 | $395 |
| Omeprazole | 37 | $334 |
| Montelukast Sodium | 25 | $331 |
| Amlodipine Besylate | 65 | $327 |
| Metoprolol Succinate | 21 | $306 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Nashville
- John AndersonNashville$1.5M
- Temidayo AbeNashville$113K
- Wayne RileyNashville$86K
- Leah CordovezNashville$64K
- Asad Al AboudNashville$44K
- Mark KouryNashville$41K
- David HeusinkveldNashville$24K
- Charlotte LohreyNashville$19K
- Malek Al-OmaryNashville$18K
- James GekasNashville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.